http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2546956-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_110a1fc818adf79c0bedb99b9fee675f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41e81b3e15b0e7ea4bbab620fa63b306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6ab11118c3d0cfd4bd6e5cefd3da714
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85cd3f2a28ecc7fa40d50d41e366476f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d431a3ee93d306ae0544ba3501dfa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237a9a7ebca34f545f4ad5e6e837e6b6
publicationDate 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2546956-C2
titleOfInvention Method of treating posterior uveitis
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be applied for the treatment of posterior uveitis. For this purpose sclerocompression, during which extreme parts of the eye bottom periphery near the toothed line of the retina are visualised through the eyelids, is created under conditions of drug mydriasis under ophthalmological control. Then laser-coagulation is performed by a contactless method. Coagulants are applied on the extreme periphery of the eye bottom, immediately in the zone of inflammation and on the boundary with healthy tissues. The diameter of the spot constitutes 100-350 mcm, with power of 400-1000 mW, impulse exposure of 0.1-0.3 sec. The general number of coagulants is 300 - 360. n EFFECT: method ensures the fast arrest of the inflammatory process with reaching stable remission with the minimal risk of addition of the secondary infection during manipulation. n 1 ex, 4 tbl, 5 dwg
priorityDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-58020-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2336849-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2299065-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7115120-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506932
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID58319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451849165
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID58319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285

Total number of triples: 28.